Clinical Trials Browser

Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Neoplasm, Residual

NCT06287814 2025-07-10

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

Recruiting

70 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Neoplasm, Residual

NCT05196087 2025-07-02

NIP IT!

Recruiting

500 enrolled

BreastDermatologicEndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Breast Neoplasms, Melanoma, Neoplasm, Residual

NCT06111105 2025-03-30

GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing CtDNA Diagnostics - Colorectal Cancer

Recruiting

590 enrolled

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05534087 2024-11-29

CLAUDIA

Phase 3 Recruiting

236 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm, Residual

NCT05965479 2024-11-12

DECIPHER

Phase 2 Recruiting

25 enrolled

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms, Neoplasm, Residual

NCT06498752 2024-08-06

MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer

Phase 2 Recruiting

102 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Neoplasm, Residual

NCT06253650 2024-06-13

TRINITY

Phase 2 Recruiting

46 enrolled

Gastrointestinal

Stomach Neoplasms, Neoplasm, Residual

NCT06449846 2024-06-10

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

Not yet recruiting

152 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence, Neoplasm, Residual

NCT06404593 2024-05-08

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

Completed

270 enrolled

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05219734 2024-03-12

MARIA

Active not recruiting

400 enrolled

GastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms, Colorectal Neoplasms, Neoplasm, Residual

NCT06287723 2024-03-01

French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)

Not yet recruiting

30 enrolled

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05969938 2023-08-01

Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

Unknown

50 enrolled

Gastrointestinal

Rectal Neoplasms, Neoplasm, Residual

NCT05952661 2023-07-19

ECMRD-001

Recruiting

56 enrolled

Gastrointestinal

Esophageal Neoplasms, Neoplasm, Residual

NCT05900583 2023-06-12

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

Unknown

50 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm, Residual

NCT05867901 2023-05-31

Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence

Recruiting

40 enrolled

GastrointestinalSarcoma

Neoplasm, Residual, Gastrointestinal Stromal Tumors

NCT03189576 2023-05-26

Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases

Phase NA Unknown

37 enrolled

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05743959 2023-05-22

ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers：A Multicenter Prospective Trial

Unknown

100 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma, Neoplasm, Residual

NCT05427669 2022-10-07

AFFORD

Phase 3 Not yet recruiting

340 enrolled

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05408897 2022-09-21

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

Recruiting

45 enrolled

GastrointestinalSarcoma

Neoplasm, Residual, Gastrointestinal Stromal Tumors

NCT02314871 2019-03-13

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

Phase 4 Completed

60 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasms, Neoplasm, Residual

NCT02900950 2016-09-15

MPM

Phase NA Completed

68 enrolled

Gastrointestinal

Margins of Excision, Neoplasms, Pancreatic Neoplasms, Neoplasm, Residual

Clinical Trials

TRACE-BTC

A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

AMPLIFY-201

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

NIP IT!

GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing CtDNA Diagnostics - Colorectal Cancer

CLAUDIA

DECIPHER

MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer

TRINITY

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

MARIA

French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)

Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

ECMRD-001

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence

Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases

ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers：A Multicenter Prospective Trial

AFFORD

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

MPM